Currently. the search for promising NK1R-positive tumor-targeting radiopharmaceuticals based on the structure of small molecular antagonists of neurokinin-1 receptor can be observed. Following this trend. we continued our evaluation of aprepitant-based 177Lu-radioconjugates in terms of future oncological applications. https://www.roneverhart.com/BenQ-MOBIUZ-EX2710U-27-4K-UHD-3840-x-2160-144-Hz-Gaming-Monitor-1ms-HDMI-DisplayPort-Built-in-Speakers/